Related Experiment Video

Updated: Feb 6, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

10.3K

Targeted Therapies in the Treatment of Sarcomas

Brianna Hoffner1, Anthony D Elias2, Victor M Villalobos1

  • 1Department of Medicine, Division of Medical Oncology, University of Colorado School of Medicine, 1665 Aurora Court, Anschutz Cancer Pavilion Rm 5310, MS 8111, Aurora, CO, 80045, USA.

Targeted Oncology
|August 26, 2018
PubMed

Insights

Approximately half of sarcomas feature molecular changes like mutations and gene fusions. Some of these alterations can be targeted with specific therapies, offering new treatment avenues for sarcoma patients.

Area of Science:

  • Oncology
  • Molecular Pathology
  • Genetics

Background:

  • Sarcomas are a heterogeneous group of cancers originating from connective tissues.
  • A significant proportion of sarcomas harbor specific molecular alterations.
  • Understanding these alterations is crucial for developing targeted therapies.

Purpose of the Study:

  • To review the role of molecular alterations in sarcoma pathology.
  • To identify oncogenic drivers within these alterations.
  • To discuss the potential of targeted agents and immunotherapies in sarcoma treatment.

Main Methods:

  • Review of existing literature on sarcoma molecular pathology.
  • Analysis of common molecular alterations (mutations, fusion genes, amplifications).
  • Evaluation of targeted therapy and immunotherapy approaches.

Main Results:

  • Around 50% of sarcomas possess distinct pathology-defining molecular alterations.
  • These alterations can function as oncogenic drivers.
  • A subset of these alterations are actionable targets for molecularly targeted agents.

Conclusions:

  • Molecular alterations are key in defining sarcoma subtypes and driving cancer progression.
  • Targeted therapies based on specific molecular alterations show promise in clinical settings.
  • Immunotherapy represents a potential future treatment strategy for sarcomas.

More Related Videos

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

15.2K
Author Spotlight: Effectiveness of Extracorporeal Shockwave Therapy in Achilles Tendinopathy Treatment03:50

Author Spotlight: Effectiveness of Extracorporeal Shockwave Therapy in Achilles Tendinopathy Treatment

Published on: August 2, 2024

2.0K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
625
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.4K
Group Therapy01:26

Group Therapy

Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
450
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K